GGrantIndex
Sort

141,003 grants matching cytokine

Gut Microbe-Derived Lipids Shape Chronic Inflammation in Cardiometabolic Disease

$743,302
Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · HL

HIV and Hepatitis C Pathogenesis & The Human Genome

$743,251
David L Thomas · Johns Hopkins University · R01 · FY2015 · DA

Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention

$743,146
Abdullah Kutlar · Augusta University · R33 · FY2024 · HL

New radiotracer development to study immune cell mobilization of granzyme proteolytic activity

$743,029
Michael John Evans · University Of California, San Francisco · R01 · FY2024 · AI

Novel IL-23 inhibitor for the treatment of alcohol associated liver disease

$742,984
Rohit Loomba · University Of California, San Diego · U01 · FY2023 · AA

Operation Core-ACISR for Late-Life Depression Prevention

$742,933
Charles F Reynolds · University Of Pittsburgh At Pittsburgh · P30 · FY2012 · MH

Atherogenic Mechanisms of Electronic Nicotine Delivery Systems

$742,925
Sanjay Srivastava · University Of Louisville · R01 · FY2020 · HL

Dietary sodium, inflammation, and salt sensitivity of blood pressure

$742,888
Deepak Gupta · Vanderbilt University Medical Center · R01 · FY2020 · HL

AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma

$742,887
Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2024 · CA

AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma

$742,887
Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2025 · CA

Balanced signaling cues to guide cell transitions in the blood lineage continuum

$742,879
Jeroen Roose · University Of California, San Francisco · R01 · FY2017 · HL

Lipoprotein (a) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease

$742,803
Thorsten M Leucker · Johns Hopkins University · R01 · FY2024 · HL

Natural Killer cells and the Immunogenetics of COVID-19

$742,765
Paul John Norman · University Of Colorado Denver · R01 · FY2021 · AI

HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans

$742,699
Shenghan Lai · Johns Hopkins University · R01 · FY2008 · DA

CCR2 Targeted Molecular Imaging and Treatment of Abdominal Aortic Aneurysms

$742,679
Mohamed A. Zayed · Washington University · R01 · FY2023 · HL

Cellular Responses

$742,677
David B. Weiner · Wistar Institute · U19 · FY2019 · AI

Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis users

$742,666
Sylvia Fitting · Univ Of North Carolina Chapel Hill · R01 · FY2022 · DA

Elucidating the role of the gut reservoir and inflammation in driving cardiovascular disease among persons living with HIV

$742,572
Cecile Delille Lahiri · Emory University · R01 · FY2022 · HL

Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis

$742,568
Yun Rose Li · Beckman Research Institute/City Of Hope · DP5 · FY2025 · OD

The roles of Lyme spirochete adhesins in hematogenous dissemination

$742,563
Jenifer L Coburn · Medical College Of Wisconsin · R01 · FY2022 · AI

Mechanisms of food allergy elicited by cutaneous sensitization

$742,501
Raif Salim Geha · Boston Children'S Hospital · R01 · FY2017 · AI

KAPOSI'S SARCOMA: PATHOGENESIS AND NOVEL THERAPY

$742,500
University Of Md Biotechnology Institute · P01 · FY2002 · CA

The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity

$742,499
Sixto Manuel Leal · University Of Alabama At Birmingham · R01 · FY2023 · AI

Targeting the Active Resolution of Inflammation for Cardiovascular Disease Prevention

$742,480
Samia Mora · Brigham And Women'S Hospital · R01 · FY2024 · HL

Malaria Immunology and Pathogenesis in Pregnant Women and Young Children

$742,469
Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI